Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Equillium stock
Learn how to easily invest in Equillium stock.
Equillium Inc is a biotechnology business based in the US. Equillium shares (EQ) are listed on the NASDAQ and all prices are listed in US Dollars. Equillium employs 45 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Equillium
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EQ – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Equillium stock price (NASDAQ: EQ)Use our graph to track the performance of EQ stocks over time.
Equillium shares at a glance
|Latest market close||$2.01|
|52-week range||$1.66 - $7.12|
|50-day moving average||$2.45|
|200-day moving average||$3.06|
|Wall St. target price||$12.83|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.25|
Buy Equillium shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Equillium stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Equillium price performance over time
|1 week (2022-09-19)||-11.45%|
|1 month (2022-08-26)||-31.40%|
|3 months (2022-06-24)||18.24%|
|6 months (2022-03-25)||-38.34%|
|1 year (2021-09-24)||-70.91%|
|2 years (2020-09-25)||-65.04%|
|3 years (2019-09-26)||3.91|
|5 years (2017-09-22)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-37.03%|
|Return on equity TTM||-115.88%|
|Market capitalisation||$77.6 million|
TTM: trailing 12 months
Equillium share dividends
We're not expecting Equillium to pay a dividend over the next 12 months.
Equillium share price volatility
Over the last 12 months, Equillium's shares have ranged in value from as little as $1.66 up to $7.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Equillium's is 1.2274. This would suggest that Equillium's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Equillium, Inc. , a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017.
Equillium in the news
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMTX, SMBC, EQ, MTCR
Equillium Announces Abstract Accepted for Presentation at ACR Convergence 2022
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CYBE, SBET, MNRL, EQ
Frequently asked questionsWhat percentage of Equillium is owned by insiders or institutions?
Currently 31.902% of Equillium shares are held by insiders and 37.836% by institutions. How many people work for Equillium?
Latest data suggests 45 work at Equillium. When does the fiscal year end for Equillium?
Equillium's fiscal year ends in December. Where is Equillium based?
Equillium's address is: 2223 Avenida De La Playa, La Jolla, CA, United States, 92037 What is Equillium's ISIN number?
Equillium's international securities identification number is: US29446K1060 What is Equillium's CUSIP number?
Equillium's Committee on Uniform Securities Identification Procedures number is: 29446K106
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert